Fabrizio Tabbò

4.0k total citations · 1 hit paper
51 papers, 1.2k citations indexed

About

Fabrizio Tabbò is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Fabrizio Tabbò has authored 51 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pulmonary and Respiratory Medicine, 29 papers in Oncology and 14 papers in Cancer Research. Recurrent topics in Fabrizio Tabbò's work include Lung Cancer Treatments and Mutations (27 papers), Cancer Genomics and Diagnostics (14 papers) and Lung Cancer Research Studies (13 papers). Fabrizio Tabbò is often cited by papers focused on Lung Cancer Treatments and Mutations (27 papers), Cancer Genomics and Diagnostics (14 papers) and Lung Cancer Research Studies (13 papers). Fabrizio Tabbò collaborates with scholars based in Italy, United States and France. Fabrizio Tabbò's co-authors include Giorgio Inghirami, Silvia Novello, Maurilio Ponzoni, Raúl Rabadán, Gianluca Gaïdano, Sami N. Malek, Amy Chadburn, Riccardo Dalla‐Favera, Vundavalli V. Murty and Govind Bhagat and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Fabrizio Tabbò

50 papers receiving 1.2k citations

Hit Papers

Genetics of Follicular Lymphoma Transformation 2014 2026 2018 2022 2014 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Genetics of Follicular Lymphoma Transformation
    2014 376 citations Fabrizio Tabbò, Giorgio Inghirami et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fabrizio Tabbò Italy 17 560 431 421 413 265 51 1.2k
Dalal Jadayel United Kingdom 9 247 0.4× 317 0.7× 449 1.1× 268 0.6× 272 1.0× 12 1.1k
Jean‐Michel Picquenot France 17 429 0.8× 508 1.2× 215 0.5× 142 0.3× 239 0.9× 48 908
Dorothy W. Pan United States 9 894 1.6× 406 0.9× 226 0.5× 437 1.1× 119 0.4× 27 1.3k
Analía Azaro Spain 18 557 1.0× 121 0.3× 569 1.4× 295 0.7× 198 0.7× 56 1.1k
Ethan Sokol United States 16 646 1.2× 240 0.6× 427 1.0× 480 1.2× 361 1.4× 83 1.3k
Lydia Sánchez-Verde Spain 18 394 0.7× 439 1.0× 465 1.1× 100 0.2× 146 0.6× 21 977
Paolo Cotzia United States 17 363 0.6× 133 0.3× 364 0.9× 439 1.1× 272 1.0× 34 1.1k
Johanna Tapper Finland 14 339 0.6× 246 0.6× 701 1.7× 229 0.6× 353 1.3× 22 1.4k
Jill Hagenkord United States 19 216 0.4× 195 0.5× 380 0.9× 293 0.7× 336 1.3× 32 985
Robert J. Behrens United States 14 484 0.9× 183 0.4× 206 0.5× 143 0.3× 144 0.5× 40 817

Countries citing papers authored by Fabrizio Tabbò

Since Specialization
Citations

This map shows the geographic impact of Fabrizio Tabbò's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabrizio Tabbò with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabrizio Tabbò more than expected).

Fields of papers citing papers by Fabrizio Tabbò

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabrizio Tabbò. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabrizio Tabbò. The network helps show where Fabrizio Tabbò may publish in the future.

Co-authorship network of co-authors of Fabrizio Tabbò

This figure shows the co-authorship network connecting the top 25 collaborators of Fabrizio Tabbò. A scholar is included among the top collaborators of Fabrizio Tabbò based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabrizio Tabbò. Fabrizio Tabbò is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Capelletto, Enrica, Fabrizio Tabbò, Francesco Leo, et al.. (2025). Therapeutic management of patients with advanced thymic malignancies: A review for clinicians. Lung Cancer. 204. 108554–108554.
2.
Toyokawa, Gouji, Francesca Bersani, Paolo Bironzo, et al.. (2023). Tumor plasticity and therapeutic resistance in oncogene-addicted non-small cell lung cancer: from preclinical observations to clinical implications. Critical Reviews in Oncology/Hematology. 184. 103966–103966. 9 indexed citations
3.
Normanno, Nicola, Antonella De Luca, Riziero Esposito Abate, et al.. (2023). Current practice of genomic profiling of patients with advanced solid tumours in Italy: the Italian Register of Actionable Mutations (RATIONAL) study. European Journal of Cancer. 187. 174–184. 9 indexed citations
4.
Salaroglio, Iris C., Fabrizio Tabbò, Sofia La Vecchia, et al.. (2023). Autocrine 17-β-Estradiol/Estrogen Receptor-α Loop Determines the Response to Immune Checkpoint Inhibitors in Non–Small Cell Lung Cancer. Clinical Cancer Research. 29(19). 3958–3973. 17 indexed citations
5.
Guo, Kai, Zhiqiang Ma, Yujiao Zhang, et al.. (2022). HDAC7 promotes NSCLC proliferation and metastasis via stabilization by deubiquitinase USP10 and activation of β-catenin-FGF18 pathway. Journal of Experimental & Clinical Cancer Research. 41(1). 91–91. 40 indexed citations
6.
Duruisseaux, M., Filippo Gustavo Dall’Olio, Patricia Iranzo, et al.. (2022). 34P RET-MAP: An international multi-center study on clinicopathologic features and treatment response in patients with NSCLC and RET fusions. Annals of Oncology. 33. S47–S48. 1 indexed citations
7.
Bertaglia, Valentina, Chiara Baratelli, Maria Lucia Reale, et al.. (2021). Performing oncological procedures during COVID-19 outbreak: apicture from an Italian cancer center. SHILAP Revista de lepidopterología. 2(5). 481–489. 1 indexed citations
8.
9.
Malapelle, Umberto, Sara Pilotto, Francesco Passiglia, et al.. (2021). Dealing with NSCLC EGFR mutation testing and treatment: A comprehensive review with an Italian real-world perspective. Critical Reviews in Oncology/Hematology. 160. 103300–103300. 12 indexed citations
10.
Bertaglia, Valentina, Calogera Pisano, Chiara Baratelli, et al.. (2021). MA12.07 Oncological Procedures and Risk Assessment of COVID-19 in Thoracic Cancer Patients: A Picture From an Italian Cancer Center. Journal of Thoracic Oncology. 16(10). S923–S924. 1 indexed citations
11.
Carnio, Simona, Annapaola Mariniello, Pamela Pizzutilo, et al.. (2020). ROC Analysis Identifies Baseline and Dynamic NLR and dNLR Cut-Offs to Predict ICI Outcome in 402 Advanced NSCLC Patients. Institutional Research Information System University of Turin (University of Turin). 1(1). 19–31. 3 indexed citations
12.
Tabbò, Fabrizio, Francesco Guerrera, Marcello Gaudiano, et al.. (2020). Kinomic profiling of tumour xenografts derived from patients with non–small cell lung cancer confirms their fidelity and reveals potentially actionable pathways. European Journal of Cancer. 144. 17–30. 2 indexed citations
13.
Remón, Jordi, Fabrizio Tabbò, Beatriz Jiménez, et al.. (2020). Sequential blinded treatment decisions in ALK-positive non-small cell lung cancers in the era of precision medicine. Clinical & Translational Oncology. 22(9). 1425–1429. 5 indexed citations
14.
Leone, Gianmarco, Consuelo Buttigliero, Rosario Francesco Di Stefano, et al.. (2020). Bipolar androgen therapy in prostate cancer: Current evidences and future perspectives. Critical Reviews in Oncology/Hematology. 152. 102994–102994. 11 indexed citations
15.
Bironzo, Paolo, Daniele Pignataro, Marco Tagliamento, et al.. (2019). P2.04-15 Association Between Opioids and Outcome of 1st Line Immunotherapy in Advanced NSCLC Patients: A Retrospective Evaluation. Journal of Thoracic Oncology. 14(10). S713–S713. 5 indexed citations
16.
Tabbò, Fabrizio & Silvia Novello. (2019). Expanding anaplastic lymphoma kinase therapeutic indication to early stage non-small cell lung cancer. Translational Lung Cancer Research. 8(S3). S290–S297. 6 indexed citations
17.
Luchini, Claudio, Nicola Veronese, Alessia Nottegar, et al.. (2018). Extranodal extension of nodal metastases is a poor prognostic moderator in non-small cell lung cancer: a meta-analysis. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 472(6). 939–947. 26 indexed citations
18.
Addeo, Alfredo, Fabrizio Tabbò, Tim Robinson, L Buffoni, & Silvia Novello. (2017). Precision medicine in ALK rearranged NSCLC: A rapidly evolving scenario. Critical Reviews in Oncology/Hematology. 122. 150–156. 39 indexed citations
19.
Guerrera, Francesco, Stéphane Renaud, Fabrizio Tabbò, et al.. (2016). Epidermal growth factor receptor mutations are linked to skip N2 lymph node metastasis in resected non-small-cell lung cancer adenocarcinomas†. European Journal of Cardio-Thoracic Surgery. 51(4). 680–688. 15 indexed citations
20.
Caliò, Anna, Alessia Nottegar, Eliana Gilioli, et al.. (2014). ALK/EML4 Fusion Gene May Be Found in Pure Squamous Carcinoma of the Lung. Journal of Thoracic Oncology. 9(5). 729–732. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dalal Jadayel Breakdown of academic impact, for papers by Jean‐Michel Picquenot Breakdown of academic impact, for papers by Dorothy W. Pan Breakdown of academic impact, for papers by Analía Azaro Breakdown of academic impact, for papers by Ethan Sokol Breakdown of academic impact, for papers by Lydia Sánchez-Verde Breakdown of academic impact, for papers by Paolo Cotzia Breakdown of academic impact, for papers by Johanna Tapper Breakdown of academic impact, for papers by Jill Hagenkord Breakdown of academic impact, for papers by Robert J. Behrens
Rankless by CCL
2026